![1-benzoyl-4-ethyl-5-[4-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)benzoyl]-1,3-dihydro-2H-imidazol-2-o…](https://static.cymitquimica.com/cas-image/1818670-1-benzoyl-4-ethyl-5-4-2-methyl-45-dihydro-1h-imidazol-1-yl-benzoyl-13-dihydro-2h-imidazol-2-one.png)
CAS: 132523-92-3 - 1-benzoyl-4-ethyl-5-[4-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)benzoyl]-1,3-dihydro-2H-imidazol-2-one
Formel:C23H22N4O3
InChl:InChI=1/C23H22N4O3/c1-3-19-20(27(23(30)25-19)22(29)17-7-5-4-6-8-17)21(28)16-9-11-18(12-10-16)26-14-13-24-15(26)2/h4-12H,3,13-14H2,1-2H3,(H,25,30)
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | CK 3197 REF: TM-T30956CAS: 132523-92-3 | - - - | 1.796,00 €~3.100,00 € | Do 16 Jan 25 |
CK 3197
CAS:132523-92-3
CK 3197 is a selective positive inotropic agent for the treatment of congestive heart failure. …
Formel:
C23H22N4O3
Farbe und Form:
Solid
Molekulargewicht:
402.45
Ref: TM-T30956
| 25mg | 1.796,00 € | ||
| 50mg | 2.352,00 € | ||
| 100mg | 3.100,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 16. Januar 2025
